Tyvaso 64 MCG kit
Ended Awarded
- Contract number
- 36C24525N1023
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $16,514
Award facts
- Contract value 100% obligated
- $16,514.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The contract is for the supply of TYVASO 64 MCG KIT, a pharmaceutical product used to treat pulmonary arterial hypertension and certain cancer conditions. The contract has a ceiling value of $16,514.15 and is structured as a firm fixed-price delivery order. It is not a set-aside contract.
United Therapeutics Corporation holds two significant Indefinite Delivery Vehicles (IDVs) with the VA National Acquisition Center, including a Blanket Purchase Agreement (BPA) valued at $207,127,385, awarded in April 2025 and extending through April 2026. This BPA allows the VA to procure specialized pharmaceutical products from United Therapeutics' portfolio, including Unituxin, Remodulin, Tyvaso, and Orenitram, to support the VA's mission of providing essential medical treatments to veterans across the country.
Quick answers
Who was awarded contract 36C24525N1023?
36C24525N1023 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 23, 2025.
How much is contract 36C24525N1023 worth?
The government has obligated $16,514 on 36C24525N1023.
Is contract 36C24525N1023 an order under another contract?
Yes. 36C24525N1023 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N1023 competed?
The extent of competition for 36C24525N1023 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award